Dr. Dong holds a Bachelor of Clinical Medicine and Master of Immunology from First Military Medical University as well as a Ph.D in Genetics from Fudan University, China. After graduating from university Dr. Dong spent 7 years in clinical medical work prior to taking a leap in order to pursue his dreams in research and development of new drugs and industrialization. Since 1995 when he embarked on his master degree research, he has his eyes set on his goals and has been undeterred in creating the conditions necessary to realise his dreams. Tirelessly he works on creating R&D platforms for new drug-technology and is committed to promoting the development and industrialization of viral vector and gene therapy. He faciliated the first stage clinical trial of the project of rAAV2 / hFIX treatment of hemophilia gene therapy, as approved by China Food and Drug Administration. Ten years of painstaking efforts and hard-work, Dr. Dong succeeded with his team in developing two new products with considerable sales return. Dr. Dong is the holder of 12 patents and has published a number of influential papers.